Company Profile
Maxion Therapeutics Limited
12560803•Private Limited With Share Capital
Get Full Access
16/04/2020
6 years
11
39
72190
very low risk
Company Overview
Registration, classification & business activity
Maxion Therapeutics Limited (12560803) is a private limited with share capital incorporated on 16/04/2020 (6 years old) and registered in london, WC2B6AH. The company operates under SIC code 72190 - other research and experimental development on natural sciences and engineering.
Maxion uses its innovative knotbody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and gpcr proteins.
Financial Overview
£53.78M
£2.84M
£50.95M
£48.52M
Key Metrics
39
Employees
11
Directors
36
Shareholders
1
Patents
Board of Directors
Innovate Grants
This company received a grant of £349947.5 for An Innovative Molecular Fusion Format That Targets Ion Channel-Driven Diseases. The project started on 01/05/2021 and ended on 31/10/2022.
This company received a grant of £1948356.0 for Development Of A Novel Class Of Ion Channel Blockers For The Treatment Of Autoimmune Disease. The project started on 01/04/2023 and ended on 31/03/2026.
Import / Export
Risk Assessment
very low risk
International Score
Future Factor
excellent
Performance Rating